Clearwater International identifies RoboPharma B.V., as a strategic target for Capsa Healthcare
Clearwater International has supported US manufacturer Capsa Healthcare (Capsa) on the identification of its recent strategic acquisition of RoboPharma B.V., a pharmacy automation solution business based in the Netherlands, which creates and implements pharmacy automation solutions for some of the largest pharmacies in Europe.
Established in 1958 and headquartered in Portland, Oregon - Capsa is a leading provider of innovative, highly engineered workflow products that increase efficiency and reduce costs, enhance medication security, and tighten inventory control across healthcare settings worldwide, Capsa’s core offerings include mobile workstations, medication management solutions, and pharmacy automation products sold to over 3,000 end customers, including leading health systems, senior care communities, and major retail and institutional pharmacies.
Capsa and Levine Leichtman Capital Partners (LLCP) will provide RoboPharma with strong financial support to accelerate their growth plans in Europe and the US. RoboPharma’s leading product position and reputation will help extend Capsa’s pharmacy automation product portfolio and provide access to innovative technology.